FDA issues new precautions on diabetes drug Byetta

NEWS IN BRIEF — Posted Sept. 8, 2008

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration has received six additional reports of hemorrhagic or necrotizing pancreatitis in patients taking Byetta, a medication given by subcutaneous injection to help treat adults with type 2 diabetes.

The agency had issued a prior alert for the drug last October after reviewing 30 postmarketing reports of acute pancreatitis in patients taking Byetta.

The drug was approved for sale in April 2005.

The FDA asked physicians and other health care professionals to instruct patients taking the drug that they should seek prompt medical care if they experience unexplained persistent severe abdominal pain, which may or may not be accompanied by vomiting.

If pancreatitis is suspected, Byetta should be discontinued, and if the diagnosis is confirmed, Byetta should not be restarted unless another cause is identified.

The manufacturer is updating the drug's label information to reflect this new information.

Note: This item originally appeared at

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn